
GAUDIUMIVF
Gaudium IVF and Women Health Limited
- IPO Status
- Closed
- Open Date
- 20 Feb 2026
- Close Date
- 24 Feb 2026
IPO Details
- Min. Investment
- ₹14,931
- Price Band
- ₹75 - ₹79
- Lot Size
- 189 shares
- Issue Size
- ₹165 Cr
- Face Value
- 5
- IPO Doc
- —
Schedule
- IPO open20 Feb 2026
- IPO close date24 Feb 2026
- Allotment date25 Feb 2026
- Funds unblock or debit25 Feb 2026
- Listing date27 Feb 2026
Financial Performance
- Revenue
- Profit
FAQs
Gaudium IVF and Women Health Limited IPO is a Mainboard IPO aggregating up to ₹165 Cr, with equity shares of face value ₹5 each. The shares are proposed to be listed on NSE.
The Gaudium IVF and Women Health Limited IPO opened on 20 Feb 2026 and closed on 24 Feb 2026. IPO Period: 20 Feb 2026 – 24 Feb 2026.
The price band for the Gaudium IVF and Women Health Limited IPO is ₹75 to ₹79 per share. Investors can bid within the specified price band, subject to the applicable IPO rules.
The minimum lot size is 189 shares. At the upper price band of ₹79, the minimum investment required is ₹14,931.
Particular Details Lot Size 189 shares Price Band ₹75 – ₹79 Minimum Investment ₹14,931 Maximum Retail Lots 13 Here is the timeline for the Gaudium IVF and Women Health Limited IPO:
IPO Event Date IPO Opens 20 Feb 2026 IPO Closes 24 Feb 2026 UPI Mandate Deadline 24 Feb 2026, 5:00 PM Basis of Allotment 25 Feb 2026 Refund Initiation 25 Feb 2026 Shares Credited 26 Feb 2026 Listing Date 27 Feb 2026 The basis of allotment for the Gaudium IVF and Women Health Limited IPO is expected to be finalised on 25 Feb 2026. Investors can check their allotment status through the registrar or relevant stock exchange website using their application details. Registrar: Bigshare Services.
The equity shares of Gaudium IVF and Women Health Limited are proposed to be listed on NSE. Proposed Listing Date: 27 Feb 2026.
The key financial performance of Gaudium IVF and Women Health Limited is:
Financial Year Revenue Profit FY24 ₹47.89 Cr ₹10.32 Cr FY25 ₹70.72 Cr ₹19.17 Cr FY26 ₹104.36 Cr ₹24.46 Cr Revenue CAGR: 47.6% | Profit CAGR: 54%. Figures are as disclosed in the company's offer documents.


